Ara
Toplam kayıt 14, listelenen: 11-14
Efficacy and Safety of Ibrutinib Use in Patients with Chronic Lymphocytic Leukemia in Real World Experiences: Results of a Prospective Multicenter Study
(Amer Soc Hematology, 2019)
[No Abstract Available]
Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data
(Amer Soc Hematology, 2019)
[No Abstract Available]
Association between blood group antigens and rheumatic valve involvement and severity in endemic areas (Meeting Abstract)
(Elsevier Science Inc, 2013)
[No Abstract Available]
Lorlatinib in ALK- or ROS1-Positive Non-Small Cell Lung Cancer Patients: Experience from an Early Access Program in Turkey
(Elsevier Science Inc, 2019)
[No Abstract Available]